Substantial Growth in Europe Nuclear Imaging Devices Market

  • Raised focus on personalized medicine is propelling the growth of the market.
  • Europe nuclear imaging devices market is registering a substantial CAGR of in the forecast period of 2019-2026.
  • Non-invasive instruments provide operational data at molecular and cellular stage that allows physicians to diagnose and assess medical conditions.

Europe Nuclear Imaging Devices Market By Product (Single Photon-Emission Computed Tomography (SPECT), Hybrid Pet, Planar Scintigraphy), Application (Oncology, Cardiology, Neurology, Other Applications), End User (Hospitals, Imaging Centers, Academic & Research Centers, Other End Users), country (Germany, Italy, U.K., France, Spain, Netherlands, Belgium, Switzerland, Turkey, Russia, Rest of Europe) – Trends and Forecast to 2026.

Nuclear imaging devices are the medical imaging instruments that use radioactive materials to diagnose the seriousness of illnesses such as cancer, cardiovascular disease, gastrointestinal, endocrine, neurological illnesses and other defects inside the brain.

Market Analysis: Europe Nuclear Imaging Devices Market

Europe nuclear imaging devices market is registering a substantial CAGR of in the forecast period of 2019-2026. This rise in the market can be attributed to the shift from separate service to variant modality and raised focus on personalized medicine.

Market Definition: Europe Nuclear Imaging Devices Market

Nuclear imaging devices are the medical imaging instruments that use radioactive materials to diagnose the seriousness of illnesses such as cancer, cardiovascular disease, gastrointestinal, endocrine, neurological illnesses and other defects inside the brain. These non-invasive instruments provide operational data at molecular and cellular stage that allows physicians to diagnose and assess medical conditions.

Get Sample Analysis of Global Market Information

Market Drivers

  • Shift from separate service to variant modality is driving the growth of the market.
  • Raised focus on personalized medicine is propelling the growth of the market.
  • Investors through public-private partnerships to reinvigorate diagnostic imaging is boosting the growth of the market.
  • Enhanced occurrence and incidence of cancer and heart disease is contributing to the growth of the market.

Market Restraints

  • The shorter half-life for radiopharmaceuticals is hampering the growth of the market.
  • Worldwide flaw of Tc-99 m is hindering the growth of the market.
  • High price of nuclear imagery devices is restricting the growth of the market.

Key Developments in the Market:

Nuclear medicine uses small amounts of radioactive material to diagnose or treat a variety of diseases. The scans help doctors diagnose many conditions, including cancers, injuries and infections.
  • In June 2019, Bracco Imaging S.p. A., a worldwide player in diagnostic imaging, has announced that it has reached a final contract to purchase Blue Earth Diagnostics, a molecular imaging firm headquartered in Oxford, U.K. With this purchase, Blue Earth Diagnostics ‘ creative goods and pipeline will considerably improve Bracco Imaging’s portfolio of accuracy medicine and personalized diagnostics, while increasing its variety of products.
  • In April 2019, Varex Imaging Corporation has finished the takeover of Direct Conversion AB, a Stockholm-based major retailer and marketer of linear array digital sensors using photon counting and charge-integrating techniques. This purchase will extend the business to the distinct geographies and grow the industry, which will lead in an increase in business income.

Get TOC of Full Report

Competitive Analysis:

Europe nuclear imaging devices market is highly fragmented and the major players have used various strategies such as new product launches, expansions, agreements, joint ventures, partnerships, acquisitions, and others to increase their footprints in this market. The report includes market shares of nuclear imaging devices market for Europe

Key Market Competitors:

A few of the major market competitors currently working in the Europe nuclear imaging devices market are Siemens, GENERAL ELECTRIC COMPANY, Digirad Corporation., Agfa-Gevaert Group.,  Neusoft Corporation, Hologic, Inc., Med-X. , Segamicorp, CANON MEDICAL SYSTEMS CORPORATION, SurgicEye GmbH,  Mediso Ltd., CMR Naviscan., DDD-Diagnostic A/S,  Bartec Technologies Ltd., Southwestern Imaging Systems and Services, LANDAUER, Ashby Gorman Baker Ltd and BERTHOLD TECHNOLOGIES GmbH & Co. KG, Incom, Inc. among others.

Only $1/click

Submit Your Ad Here

Rashi Pande

About Us Data Bridge Market Research is a versatile market research and consulting firm with over 500 analysts working in different industries. We have catered more than 40% of the fortune 500 companies globally and have a network of more than 5000+ clientele around the globe. 
https://www.databridgemarketresearch.com/

Leave a Reply